The Magazine for Sleep Professionals
Sunday, June 21, 2026
As the prevalence of atrial fibrillation (AF) continues to rise, particularly among the aging population, its connection with obstructive sleep apnea (OSA) has become increasingly evident.1 Patients with AF seeking treatment for OSA often present with a complex medical history that includes a number of comorbidities, such as hypertension, acid […]
Aesyra, a medical device company pioneering oral appliance technologies to improve sleep, today announced it has raised $3 million in seed financing. The round was led by Supermoon Capital (USA), the world’s first fund focused on sleeptech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher […]
Vivos Therapeutics, Inc. announced it has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) for treating severe obstructive sleep apnea (OSA) in adults using the Vivos’ removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances. Vivos’ CARE appliances include the flagship DNA oral appliance, the mRNA […]
ProSomnus, Inc. has announced the completion of a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital, LLC. ProSomnus’s Executive Chair, Chief Executive Officer, and Chief Financial Officer are also participating in the financing. A description of the terms of the offering can […]
ProSomnus, Inc. announced plans to design a head-to-head clinical trial comparing its precision oral appliance therapy (OAT) and hypoglossal nerve stimulation (HGNS) in treating patients with severe OSA. The clinical trial plans follow updated results from the First Line Obstructive Sleep Apnea Treatment Study (FLOSAT), a prospective, independent, head-to-head, crossover […]
SomnoMed North America announces Nexus Dental Systems (Nexus) as their preferred partner to offer sleep dentistry training and medical billing in the DOD, VA and commercial market segments. “This partnership significantly enhances the objectives of SomnoMed’s Medical Initiative by further enabling and expanding collaborative patient treatment pathways between medical prescribers, […]
ProSomnus, Inc. announced the presentation of four abstracts at the 2023 American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, held May 19-21 in Philadelphia, Pennsylvania, and two abstracts at the American Thoracic Society (ATS) 2023 International Conference, held May 19-24 in Washington, D.C. The data presented at both meetings […]
ProSomnus, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in this family, including already-issued USPN 10,213,280 and USPN 9,808,327. ProSomnus’s intellectual property […]
Glidewell Clinical Education is introducing a new promotion for free hotel accommodations for those who attend a live course in one of their state-of-the-art training centers in Irvine, California, or Louisville, Kentucky. This offer aims to relieve some of the financial load for attendees who are not local to the […]
By Ashley Spooner, DDS, D.ABDSM Introduction: Undiagnosed and untreated sleep apnea is a serious and growing health problem. The adult population in the United States has a prevalence of obstructive sleep apnea (OSA) of 12%.1 This prevalence is rising at an estimated 14% growth rate between 2022-2027 due to factors […]
